Pharmacogenomics - Health Technology Insights

FDA-Warning-Raises-New-Questions-About-GLP-1-Drug-Safety

FDA Warning Raises New Questions About GLP-1 Drug Safety

March 13, 2026

First Patient Treated With Leqembi (lecanemab) in the Nordics

October 14, 2025

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

October 2, 2025

CSL Vifor and Travere Therapeutics Support Updated KDIGO IgA Nephropathy Guidelines

CSL Vifor and Travere Therapeutics Support Updated KDIGO IgA Nephropathy Guidelines

September 26, 2025

Kashiv and JAMP Launch PEXEGRA and FILRA Biosimilars in Canada

September 24, 2025

EMA Recommends Approval for Alvotech’s Gobivaz Biosimilar

EMA Recommends Approval for Alvotech’s Gobivaz Biosimilar

September 22, 2025

ForCast and KORU Partner on New Antibiotic Infusion Therapy

ForCast and KORU Partner on New Antibiotic Infusion Therapy

September 18, 2025

SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics

September 16, 2025

Tandem Study: Type 2 Diabetes Patients Benefit from AID

September 16, 2025

Raludotatug Deruxtecan Gets FDA Breakthrough for Ovarian Cancer

September 15, 2025

Predictive Oncology, Every Cure Partner on Cancer Drug Reuse

September 4, 2025

Syantra Launches Immuno-Oncology Drug Discovery Division

September 4, 2025

Recent Posts

Unifying IDV and Voice authentication to Stop Medical Fraud

Unifying IDV and Voice Authentication to Stop Medical Fraud

Qualtrics Acquires Press Ganey Forsta for $6.75 Billion to Expand Experience Management Leadership

Qualtrics Acquires Press Ganey Forsta for $6.75 Billion to Expand Experience Management Leadership

Defending the Hospital Front Door: The 2026 Identity Mandate

Defending the Hospital Front Door: The 2026 Identity Mandate

Coral raises $12.5M to automate healthcare’s back office by working with, not against, the fax machine

Coral Raises $12.5m to Automate Healthcare’s Back Office by Working With, Not Against, the Fax Machine

Coral-Vendor-Expert-Review-for-DME-and-Infusion-Leaders

Coral Vendor Expert Review for DME and Infusion Leaders

Zenith Genomics by Natera Targets Rare Disease Diagnosis

Zenith Genomics by Natera Targets Rare Disease Diagnosis